HITRUST CSF Certification validates ZappRx is committed to meeting key regulations and protecting sensitive information.
BOSTON--(BUSINESS WIRE)--ZappRx, a leading healthcare technology company that reduces the administrative burden associated with prescribing specialty medications, today announced the ZappRx platform has earned Certified status for information security by HITRUST.
HITRUST CSF Certified status demonstrates that the organization’s aforementioned
cloud-based, all-inclusive specialty drug prescribing ZappRx platform has met key regulations and industry-defined requirements and is appropriately managing risk. This achievement places ZappRx in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards and frameworks, and incorporating a risk-based approach, the HITRUST CSF helps organizations address these challenges through a comprehensive and flexible framework of prescriptive and scalable security controls.
“Organizations, like ours, are under great pressure to meet complex compliance requirements that include technical and process elements such as HIPAA, NIST, ISO and COBIT,” said Kyle Kruczek, Director, Information Security at ZappRx. “The HITRUST CSF is the gold-standard that needs to be met, and ZappRx is pleased to be able to demonstrate its commitment by achieving HITRUST CSF Certification.”
“The HITRUST CSF has become the information protection framework for the health care industry, and the CSF Assurance program is bringing a new level of effectiveness and efficiency to third-party assurance,” said Ken Vander Wal, Chief Compliance Officer, HITRUST. “The HITRUST CSF Certification is now the benchmark that organizations required to safeguard PHI are measured against with regards to information protection.”
ZappRx streamlines the complex process required to order specialty medications, increasing efficiencies when collecting and maintaining the myriad requisite information for specialty prescribing — including pharmacy information, payer/prior authorization requirements, and relevant clinical history. ZappRx then enables providers, pharmacists, and payers to digitally interact with one another to fill a prescription, reducing the need for faxes and phone calls. The platform is currently live in three disease areas, including Pulmonary Arterial Hypertension (PAH), Idiopathic Pulmonary Fibrosis (IPF), and Cystic Fibrosis, with plans to expand to support prescribing for other areas, including gastroenterology, rheumatology, neurology, and oncology conditions.